Rehman, Asad Ur
Khan, Parvez
Maurya, Shailendra Kumar
Siddiqui, Jawed A.
Santamaria-Barria, Juan A.
Batra, Surinder K.
Nasser, Mohd Wasim http://orcid.org/0000-0003-2070-4972
Funding for this research was provided by:
National Cancer Institute (R01CA218545, R01CA241752)
National Institutes of Health (P01 CA217798)
U.S. Department of Defense (W81XWH-21-1-0640)
Article History
Received: 15 December 2021
Accepted: 19 April 2022
First Online: 10 May 2022
Declarations
:
: Not applicable for this review.
: All authors agree with the content of the manuscript and consent to publication.
: SKB is co-founder of Sanguine Diagnostics and Therapeutics, Inc. Other authors declare no competing interests.